Related references
Note: Only part of the references are listed.Pediatric Pharmacokinetics and Dose Predictions: A Report of a Satellite Meeting to the 10th Juvenile Toxicity Symposium
Bianca D. van Groen et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2021)
The scaling of human basal and resting metabolic rates
Heather M. Bowes et al.
EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY (2021)
Resting Energy Expenditure Prediction Equations in the Pediatric Population: A Systematic Review
Jimena Fuentes-Servin et al.
FRONTIERS IN PEDIATRICS (2021)
Predicted basal metabolic rate and cancer risk in the European Prospective Investigation into Cancer and Nutrition
Nathalie Kliemann et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Prediction of Clearance and Dose ofMidazolam in Preterm and Term Neonates: A Comparative Study Between Allometric Scaling and Physiologically Based Pharmacokinetic Modeling
Najia Mansoor et al.
AMERICAN JOURNAL OF THERAPEUTICS (2019)
Scaling beta-lactam antimicrobial pharmacokinetics from early life to old age
Dagan O. Lonsdale et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)
A Comparative Study Between Allometric Scaling and Physiologically Based Pharmacokinetic Modeling for the Prediction of Drug Clearance From Neonates to Adolescents
Iftekhar Mahmood et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Human behavior and lognormal distribution. A kinetic description
Stefano Gualandi et al.
MATHEMATICAL MODELS & METHODS IN APPLIED SCIENCES (2019)
A Pediatric Covariate Function for CYP3A-Mediated Midazolam Clearance Can Scale Clearance of Selected CYP3A Substrates in Children
Janneke M. Brussee et al.
AAPS JOURNAL (2019)
Vancomycin Pharmacokinetics Throughout Life: Results from a Pooled Population Analysis and Evaluation of Current Dosing Recommendations
Pieter J. Colin et al.
CLINICAL PHARMACOKINETICS (2019)
The pathogenesis of obesity
Sabrina M. Oussaada et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2019)
Scaling Drug Clearance from Adults to the Young Children for Drugs Undergoing Hepatic Metabolism: A Simulation Study to Search for the Simplest Scaling Method
E. A. M. Calvier et al.
AAPS JOURNAL (2019)
A Retrospective Evaluation of Allometry, Population Pharmacokinetics, and Physiologically-Based Pharmacokinetics for Pediatric Dosing Using Clearance as a Surrogate
Qier Wu et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2019)
Children Are Not Small Adults, but Can We Treat Them As Such?
Elke H. J. Krekels et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2019)
Normalizing resting energy expenditure across the life course in humans: challenges and hopes
Manfred J. Mueller et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2018)
Estimation of Resting Energy Expenditure Using Predictive Equations in Critically Ill Children: Results of a Systematic Review
Corinne Jotterand Chaparro et al.
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION (2018)
Age- and Bodyweight-dependent Allometric Exponent Model for Scaling Clearance and Maintenance Dose of Theophylline From Neonates to Adults
Million A. Tegenge et al.
THERAPEUTIC DRUG MONITORING (2018)
Scaling clearance in paediatric pharmacokinetics: All models are wrong, which are useful?
Eva Germovsek et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Allometric Scaling of Clearance in Paediatric Patients: When Does the Magic of 0.75 Fade?
Elisa A. M. Calvier et al.
CLINICAL PHARMACOKINETICS (2017)
Allometry Is a Reasonable Choice in Pediatric Drug Development
Tao Liu et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Prediction of Human Glomerular Filtration Rate from Preterm Neonates to Adults: Evaluation of Predictive Performance of Several Empirical Models
Iftekhar Mahmood et al.
AAPS JOURNAL (2016)
A bodyweight-dependent allometric exponent model for scaling clearance of clotting factor VIII and IX from infants to adults
I. Mahmood et al.
HAEMOPHILIA (2016)
Metabolic acceleration and the evolution of human brain size and life history
Herman Pontzer et al.
NATURE (2016)
Prediction of drug clearance in children
Frantz Foissac et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Is metabolic rate a universal 'pacemaker' for biological processes?
Douglas S. Glazier
BIOLOGICAL REVIEWS (2015)
Prediction of Drug Clearance in Children: an Evaluation of the Predictive Performance of Several Models
Iftekhar Mahmood et al.
AAPS JOURNAL (2014)
The allometric exponent for scaling clearance varies with age: a study on seven propofol datasets ranging from preterm neonates to adults
Chenguang Wang et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Dosing in Children: A Critical Review of the Pharmacokinetic Allometric Scaling and Modelling Approaches in Paediatric Drug Development and Clinical Settings
Iftekhar Mahmood
CLINICAL PHARMACOKINETICS (2014)
Metabolic costs and evolutionary implications of human brain development
Christopher W. Kuzawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Understanding dosing: children are small adults, neonates are immature children
Brian J. Anderson et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2013)
Developmental Changes in Morphine Clearance Across the Entire Paediatric Age Range are Best Described by a Bodyweight-Dependent Exponent Model
Chenguang Wang et al.
CLINICAL DRUG INVESTIGATION (2013)
A Pharmacokinetic Standard for Babies and Adults
Nick Holford et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Body Weight-Dependent Pharmacokinetics of Busulfan in Paediatric Haematopoietic Stem Cell Transplantation Patients Towards Individualized Dosing
Imke H. Bartelink et al.
CLINICAL PHARMACOKINETICS (2012)
First dose in children: physiological insights into pharmacokinetic scaling approaches and their implications in paediatric drug development
Ashley Strougo et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2012)
A Bodyweight-Dependent Allometric Exponent for Scaling Clearance Across the Human Life-Span
Chenguang Wang et al.
PHARMACEUTICAL RESEARCH (2012)
Predicting weight using postmenstrual age - neonates to adults
Anita L. Sumpter et al.
PEDIATRIC ANESTHESIA (2011)
Dosing in Children
N. Holford
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Mixed-power scaling of whole-plant respiration from seedlings to giant trees
Shigeta Mori et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Shifts in metabolic scaling, production, and efficiency across major evolutionary transitions of life
John P. DeLong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Developmental Pharmacokinetics
Gail D. Anderson
SEMINARS IN PEDIATRIC NEUROLOGY (2010)
Mechanistic Basis of Using Body Size and Maturation to Predict Clearance in Humans
Brian J. Anderson et al.
DRUG METABOLISM AND PHARMACOKINETICS (2009)
Human renal function maturation: a quantitative description using weight and postmenstrual age
Malin M. Rhodin et al.
PEDIATRIC NEPHROLOGY (2009)
Mechanism-based concepts of size and maturity in pharmacokinetics
B. J. Anderson et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2008)
Facilitation of drug evaluation in children by population methods and modelling
Michel Tod et al.
CLINICAL PHARMACOKINETICS (2008)
Pharmacokinetic prediction for intravenous β-lactam antibiotics in pediatric patients
Kenji Shimamura et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2007)
Determinants of Drug Metabolism in Early Neonatal Life
Karel Allegaert et al.
CURRENT CLINICAL PHARMACOLOGY (2007)
Prediction of drug clearance in children from adults: a comparison of several allometric methods
I Mahmood
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Ontogeny of drug elimination by the human kidney
N Chen et al.
PEDIATRIC NEPHROLOGY (2006)
Prediction of the clearance of eleven drugs and associated variability in neonates, infants and children
Trevor N. Johnson et al.
CLINICAL PHARMACOKINETICS (2006)
A mechanistic approach for the scaling of clearance in children
Andrea N. Edginton et al.
CLINICAL PHARMACOKINETICS (2006)
Development and evaluation of a generic physiologically based pharmacokinetic model for children
Andrea N. Edginton et al.
CLINICAL PHARMACOKINETICS (2006)
Beyond the '3/4-power law': variation in the intra- and interspecific scaling of metabolic rate in animals
DS Glazier
BIOLOGICAL REVIEWS (2005)
Prediction of drug disposition in infants and children by means of physiologically based pharmacokinetic (PBPK) modelling:: theophylline and midazolam as model drugs
S Björkman
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Population pharmacokinetic studies in pediatrics: Issues in design and analysis
B Meibohm et al.
AAPS JOURNAL (2005)
The ontogeny of human drug-metabolizing enzymes: Phase II conjugation enzymes and regulatory mechanisms
DG McCarver et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
The ontogeny of human drug-metabolizing enzymes: Phase I oxidative enzymes
RN Hines et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Ontogeny of hepatic and renal systemic clearance pathways in infants - Part I
J Alcorn et al.
CLINICAL PHARMACOKINETICS (2002)
Ontogeny of hepatic and renal systemic clearance pathways in infants - Part II
J Alcorn et al.
CLINICAL PHARMACOKINETICS (2002)
A general model for ontogenetic growth
GB West et al.
NATURE (2001)
Basal metabolic rate in children with a solid tumour
E den Broeder et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2001)
Share Paper
